
Partner network
The Institute works with specialised clinics and laboratories, selecting partners according to the specifics of the task and the patient's location.

The Institute is open to joint projects that develop advanced programmes in oncology and gerontology.

The Institute offers strategic partners a ready-made technology with proven effectiveness. The entire cycle — from synthesis of the molecule to clinical trials — has been carried out using the Institute's own resources. We have created working protocols for a wide range of cancer sites, and the preclinical stage is 100% complete.
We are open to partnerships to jointly develop individual areas. Access to detailed documentation is granted after a non-disclosure agreement (NDA) is signed.
Developing clinical trials for specific tumour sites.
Registering the Institute's developments and entering new markets.
Applying the Institute's protocols and carrying out individual laboratory studies.
Developing the gerontology direction based on completed preclinical studies.
Long-term partnership and funding of the Institute's programmes.

The Institute works with specialised clinics and laboratories, selecting partners according to the specifics of the task and the patient's location.
Tell us about your organisation and the area you would like to discuss. The Institute's team will respond personally.